Illumina (ILMN) Tops Q4 EPS by 13c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Illumina (ILMN) PT Raised to $135 at JPMorgan
February 9, 2024 10:27 AM ESTJPMorgan analyst Rachel Vatnsdal raised the price target on Illumina (NASDAQ: ILMN) to $135.00 (from $110.00) while maintaining a Neutral rating.
The analyst comments "Illumina (ILMN) reported 4Q revenues of $1.12B in line with pre-announcement (+4% y/y reported, +4% cc) and above the then-consensus of $1.07B. The quarter was driven by 79 NovaSeq X shipments (vs. guide of ~62 guided at midpoint) bringing the total installed base to 352 instruments, paired with... More
